BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 35721884)

  • 1. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gd-EOB-DTPA-enhanced MRI-a noninvasive and short-term assessment method for liver necroinflammation after direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C.
    Li A; Wu J; Cheng J; Feng C; Liu W; Li Y; Rao H; Huang R; Zhou G; Hong N; Wang Y
    Abdom Radiol (NY); 2022 Jan; 47(1):174-183. PubMed ID: 34664096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis.
    Wu WP; Hoi CI; Chen RC; Lin CP; Chou CT
    Medicine (Baltimore); 2017 Oct; 96(42):e8339. PubMed ID: 29049250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.
    Bachofner JA; Valli PV; Kröger A; Bergamin I; Künzler P; Baserga A; Braun D; Seifert B; Moncsek A; Fehr J; Semela D; Magenta L; Müllhaupt B; Terziroli Beretta-Piccoli B; Mertens JC
    Liver Int; 2017 Mar; 37(3):369-376. PubMed ID: 27678216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment.
    Niu B; Zang W; Zhou H; Mi Y; Lu C; Li P
    BMC Gastroenterol; 2023 Apr; 23(1):102. PubMed ID: 37013471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
    Huang R; Rao H; Yang M; Gao Y; Wang J; Jin Q; Ma D; Wei L
    Dig Dis Sci; 2020 May; 65(5):1491-1500. PubMed ID: 31654313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.
    Pan S; Wang XQ; Guo QY
    World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary phase images using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI as an imaging surrogate for the albumin-bilirubin grading system.
    Takatsu Y; Kobayashi S; Miyati T; Shiozaki T
    Eur J Radiol; 2016 Dec; 85(12):2206-2210. PubMed ID: 27842668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
    Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver.
    Okada M; Murakami T; Yada N; Numata K; Onoda M; Hyodo T; Inoue T; Ishii K; Kudo M
    J Magn Reson Imaging; 2015 Feb; 41(2):329-38. PubMed ID: 24343840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Fibrosis Staging with Gadolinium Ethoxybenzyl Diethylenetriamine Penta-Acetic Acid-enhanced: A Systematic Review and Meta-analysis.
    Lai LY; Huang MP; Su S; Shu J
    Curr Med Imaging; 2021; 17(7):854-863. PubMed ID: 33256584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of liver fibrosis with gadoxetic acid-enhanced MRI: comparisons with transient elastography, ElastPQ, and serologic fibrosis markers.
    Jang HJ; Min JH; Lee JE; Shin KS; Kim KH; Choi SY
    Abdom Radiol (NY); 2019 Aug; 44(8):2769-2780. PubMed ID: 31041497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents.
    Hsu WF; Lai HC; Su WP; Lin CH; Chuang PH; Chen SH; Chen HY; Wang HW; Huang GT; Peng CY
    BMC Gastroenterol; 2019 Apr; 19(1):63. PubMed ID: 31029101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of hepatocellular carcinoma development after sustained virologic response in HCV infection.
    Toyoda H; Yasuda S; Shiota S; Sone Y; Maeda A; Kaneoka Y; Kumada T; Tanaka J
    Aliment Pharmacol Ther; 2021 Jun; 53(12):1309-1316. PubMed ID: 33896023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology and the predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy.
    Huang R; Rao HY; Yang M; Gao YH; Wang J; Jin Q; Ma DL; Wei L
    World J Gastroenterol; 2021 Feb; 27(5):404-415. PubMed ID: 33584072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating liver function in a large cirrhotic cohort: Signal intensity of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI.
    Ippolito D; Famularo S; Giani A; Orsini EB; Pecorelli A; Pinotti E; Gandola D; Romano F; Sironi S; Bernasconi DP; Gianotti L
    Dig Liver Dis; 2019 Oct; 51(10):1438-1445. PubMed ID: 31153787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic uptake index in the hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine penta acetic acid-enhanced magnetic resonance imaging estimates functional liver reserve and predicts post-hepatectomy liver failure.
    Donadon M; Lanza E; Branciforte B; Muglia R; Lisi C; Pedicini V; Poretti D; Famularo S; Balzarini L; Torzilli G
    Surgery; 2020 Sep; 168(3):419-425. PubMed ID: 32600880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining 99mTc-GSA single-photon emission-computed tomography and Gd-EOB-DTPA-enhanced magnetic resonance imaging for staging liver fibrosis.
    Tokorodani R; Kume T; Daisaki H; Hayashi N; Iwasa H; Yamagami T
    Medicine (Baltimore); 2023 Feb; 102(7):e32975. PubMed ID: 36800578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY; Chang WC; Chou CT; Chen RC
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.